SavedAdd your journal

Journals / Ulusal Cerrahi Dergisi / 2008 / Cilt: 24 - Sayı: 1

A case report peritoneal carcinomatosis of colorectal cancer treated with cytoreduction and hyperthermic intraperitoneal chemotherapy, and an overview of medical literature

Kolorektal kanser kaynaklı peritoneal karsinomatozis olgusunda sitoredüksiyon ve hipertermik intraperitoneal kemoterapi uygulaması ve literatürün gözden geçirilmesi

Cem TERZİ
Uğur YILMAZ
Can YAKUT
Mücahit ÖZBİLGİN
Funda OBUZ
Sülen SARIOĞLU
Mehmet FÜZÜN
Pages
33–41
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We also present the description of technique of hyperthermic intraperitoneal chemothereapy and an overview of the releted medical literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The peritoneum is one of the most frequent site of the metastasis of colorectal cancer.
📊
Key Findings & Data:Until recently, treatment of peritoneal carcinomatosis has been limited to palliative surgery and systemic chemotherapy with a median survival 4-12 months.
💡
Conclusion & Impact:We also present the description of technique of hyperthermic intraperitoneal chemothereapy and an overview of the releted medical literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The peritoneum is one of the most frequent site of the metastasis of colorectal cancer. Until recently, treatment of peritoneal carcinomatosis has been limited to palliative surgery and systemic chemotherapy with a median survival 4-12 months. But, cytoreductive surgery (including peritonectomies) and hyperthermic intraperitoneal chemothereapy has resulted in an unprecedented median survival > 20 months. The use of hyperthermia as an adjunct to chemotherapy in the treatment of peritoneal carcinomatosis of colorectal cancer is a new and very promising technique. We, herein, report of the first case of Turkey who had cytoreductive surgery and hyperthermic intraperitoneal chemothereapy with the diagnosis of peritoneal carcinomatosis of colon cancer. We also present the description of technique of hyperthermic intraperitoneal chemothereapy and an overview of the releted medical literature.

🔖

Cite This Article

TERZİ, C., YILMAZ, U., YAKUT, C., ÖZBİLGİN, M., OBUZ, F., SARIOĞLU, S., FÜZÜN, M. (2008). A case report peritoneal carcinomatosis of colorectal cancer treated with cytoreduction and hyperthermic intraperitoneal chemotherapy, and an overview of medical literature. Ulusal Cerrahi Dergisi, Cilt: 24 - Sayı: 1, 33–41. https://ajindex.com/articles/325771

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Koppe MJ, Boerman OC, Oyen WJ et al. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 2006; 243:212–222
  2. Cintron JR, Pearl RK. Colorectal cancer and peritoneal carcinomatosis. Semin Surg Oncol 1996; 12:267-278
  3. Knorr C, Reingruber B, Meyer T et al. Peritoneal carcinomatosis of colorectal cancer: inciden-ces, prognosis and treatment modalities. Int J Colorectal Dis 2004; 19:181–187
  4. Sugarbaker PH, Gianola FJ, Speyer JL et al. Prospective randomized trial of intravenous vs intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer. Semin Oncol 1985; 12:101-111
  5. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 apendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221:124–132
  6. Sugarbaker PH, Schellinx ME, Chang D et al. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 1996; 20:585–591
  7. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221:29–42
  8. Schellinx ME, von Meyenfeldt MF, Sugarbaker PH. Peritoneal carcinomatosis from adenocarcinoma of the colon. Cancer Treat Res 1996; 81:247-260 9. Los G, McVie JG. Experimental and clinical status of intraperitoneal chemotherapy. Eur J Cancer 1990; 26:755-762
  9. Markman M. Intraperitoneal chemotherapy. Semin Oncol 199; 18: 248-254
  10. Engelhardt R. Hyperthermia and drugs. Recent results. Cancer Res 1987; 104: 136-203
  11. Van Ruth S, Verwaal VJ, Zoetmulder FA. Pharmacokinetics of intraperitoneal mitomycin C. Surg Oncol Clin N Am 2003;12:771-780
  12. Füzün M, Sökmen S, Terzi C, Canda AE. Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience.Acta Chir Iugosl. 2006; 53:17-21
  13. Van Ruth S, Mathot RA, Sparidans RW et al. Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy. Clin Pharmacokinet 2004; 43:131-143
  14. Elias D, Bonnay M, Puizillou JM et al. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol 2002; 13:267-272
  15. Elias D, Marsaud M, Ede C et al. Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol 2004; 15:781-785
  16. Elias D. Chemotherapies, carrier s